Self-Inspection Report
Securities Code: 301033
Securities Abbreviation: Maipu Medical
Announcement Number: 2026-037
Guangzhou Maipu Regenerative Medicine Technology Co., Ltd. (hereinafter referred to as "the Company") and all members of the Board of Directors guarantee that the content of this information disclosure is true, accurate, and complete, with no false records, misleading statements, or significant omissions.
On May 18, 2026, the Company held the 20th meeting of the 3rd Board of Directors, where it reviewed and approved the proposal regarding the "Draft of the 2026 Restricted Stock Incentive Plan" and related proposals. For specific details, please refer to the announcement disclosed by the Company on May 19, 2026, on the Giant Tide Information Network (http://www.cninfo.com.cn).